Cerebral Palsy (CP) is the most common motor disability in childhood. Population-based studies from around the world report that the prevalence estimates of Cerebral Palsy range from 1.5 to more than 4 per 1,000 live births or children of a defined age range. The overall birth prevalence of CP is approximately 2 per 1,000 live births.
As per Toyokawa et al. (2016), the cerebral palsy prevalence in 5‐ to 9‐year‐olds in Japan was estimated at 2.27/1000. Peak cerebral palsy prevalence was estimated at 2.39/1000 at age 4 years.
As per the study conducted by Steven et al. (2018) studies in Australia, Europe, Canada, Sweden, and Japan have provided evidence for a declining prevalence of Cerebral Palsy over time, mostly among low-birth-weight and preterm infants.
DelveInsight's "Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Cerebral Palsy Market, historical and forecasted epidemiology, the pipeline insight as well as the Cerebral Palsy market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Cerebral Palsy market report also covers emerging drugs, current treatment practices, Cerebral Palsy market shares of the individual therapies, current and forecasted Cerebral Palsy Market Size segmented by seven major markets. The report provides a detailed current Cerebral Palsy treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Cerebral Palsy Market Analysis
The global cerebral palsy market is driving owing to the growing prevalence of cerebral palsy coupled with increasing awareness about the condition. Moreover, the growing adoption of medications for controlling the symptoms of cerebral palsy is anticipated to propel the market growth.
The Cerebral Palsy market analysis section of the report helps to build a detailed comprehension of the historic, current, and forecasted Cerebral Palsy market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers and demand for better technology.
Cerebral Palsy Epidemiology Forecast
The Cerebral Palsy epidemiology section covers insights about historical and current Cerebral Palsy patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Cerebral Palsy Pipeline Analysis and Key Companies
The Cerebral Palsy Pipeline and Drugs Uptake section focus on the rate of uptake of the potential drugs recently launched in the Cerebral Palsy market or expected to get launched in the market during the study period. The analysis covers the Cerebral Palsy market uptake by drugs; patient uptake by therapies; and sales of each drug.
Companies across the globe are working towards the development of new treatment therapies for Cerebral Palsy (CP). Some of the key companies in the global Cerebral Palsy market include:
Allergan Plc,
Cellular Biomedicine Group
Merck & Co., Inc.
Pfizer, Inc.
GlaxoSmithKline Plc
Abbott Laboratories
Acorda Therapeutics, Inc.
Medtronic
Meridigen Biotech
Merz Pharmaceuticals
GW Pharmaceuticals
Cell Cure Neurosciences
And others.
Cerebral Palsy Therapies Covered:
TEV-50717
Robotic Ankle Assist Device (RAAD)
Umbilical Cord Mesenchymal Stem Cells
And others.
Source: Cerebral Palsy Market Growth